S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
NASDAQ:ADUS

Addus HomeCare - ADUS Competitors

$104.14
-0.20 (-0.19%)
(As of 03/29/2023 12:00 AM ET)
Add
Compare
Today's Range
$101.32
$105.73
50-Day Range
$97.94
$112.28
52-Week Range
$73.65
$114.99
Volume
84,946 shs
Average Volume
91,537 shs
Market Capitalization
$1.68 billion
P/E Ratio
36.54
Dividend Yield
N/A
Price Target
$113.00

ADUS vs. AHCO, AMED, EHAB, LHCG, OPCH, IRWD, SILK, XNCR, SKIN, and VCYT

Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include AdaptHealth (AHCO), Amedisys (AMED), Enhabit (EHAB), LHC Group (LHCG), Option Care Health (OPCH), Ironwood Pharmaceuticals (IRWD), Silk Road Medical (SILK), Xencor (XNCR), Beauty Health (SKIN), and Veracyte (VCYT). These companies are all part of the "medical" sector.

Addus HomeCare vs.

Addus HomeCare (NASDAQ:ADUS) and AdaptHealth (NASDAQ:AHCO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, valuation, profitability, risk, dividends, earnings and analyst recommendations.

97.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 86.3% of AdaptHealth shares are owned by institutional investors. 4.5% of Addus HomeCare shares are owned by insiders. Comparatively, 17.3% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Addus HomeCare presently has a consensus price target of $113.00, suggesting a potential upside of 8.24%. AdaptHealth has a consensus price target of $25.33, suggesting a potential upside of 91.19%. Given AdaptHealth's higher possible upside, analysts plainly believe AdaptHealth is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
AdaptHealth
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

Addus HomeCare received 206 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 66.51% of users gave Addus HomeCare an outperform vote while only 63.06% of users gave AdaptHealth an outperform vote.

CompanyUnderperformOutperform
Addus HomeCareOutperform Votes
276
66.51%
Underperform Votes
139
33.49%
AdaptHealthOutperform Votes
70
63.06%
Underperform Votes
41
36.94%

AdaptHealth has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$951.12 million1.77$46.03 million$2.8536.63
AdaptHealth$2.97 billion0.60$69.32 million$0.2650.96

In the previous week, Addus HomeCare had 2 more articles in the media than AdaptHealth. MarketBeat recorded 8 mentions for Addus HomeCare and 6 mentions for AdaptHealth. Addus HomeCare's average media sentiment score of 0.57 beat AdaptHealth's score of 0.49 indicating that Addus HomeCare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AdaptHealth
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Addus HomeCare has a net margin of 4.84% compared to AdaptHealth's net margin of 2.33%. Addus HomeCare's return on equity of 8.58% beat AdaptHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare 4.84% 8.58% 5.44%
AdaptHealth 2.33% 3.34% 1.37%

Addus HomeCare has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.

Summary

Addus HomeCare beats AdaptHealth on 11 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.68B$3.45B$4.35B$5.89B
Dividend YieldN/A0.29%2.42%4.51%
P/E Ratio36.6320.02105.7212.63
Price / Sales1.772.293,535.8057.72
Price / Cash24.7117.8419.6522.50
Price / Book2.654.174.545.10
Net Income$46.03M-$67.77M$114.97M$191.35M
7 Day Performance5.50%1.88%1.17%1.46%
1 Month Performance-3.90%-7.14%-6.56%-5.44%
1 Year Performance18.10%-7.87%-15.44%-18.35%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AHCO
AdaptHealth
3.0061 of 5 stars
$13.74
-4.6%
$25.33
+84.4%
-15.6%$1.85B$2.97B52.8510,900
AMED
Amedisys
2.8405 of 5 stars
$72.59
-2.1%
$119.53
+64.7%
-57.0%$2.36B$2.22B19.9420,000Short Interest ↓
EHAB
Enhabit
1.9073 of 5 stars
$13.74
+0.3%
$16.50
+20.1%
N/A$681.78M$1.08B0.0010,593
LHCG
LHC Group
1.4123 of 5 stars
$169.81
+0.5%
$170.00
+0.1%
+8.0%$5.27B$2.22B82.8330,000Analyst Report
High Trading Volume
OPCH
Option Care Health
2.9088 of 5 stars
$31.06
-2.6%
$40.50
+30.4%
+11.7%$5.65B$3.94B37.428,058Positive News
IRWD
Ironwood Pharmaceuticals
2.1386 of 5 stars
$10.42
-1.6%
$14.67
+40.8%
-16.9%$1.61B$410.60M10.74219Insider Selling
Positive News
SILK
Silk Road Medical
2.002 of 5 stars
$41.10
-2.2%
$52.83
+28.5%
-2.0%$1.58B$138.64M-26.52352
XNCR
Xencor
2.1357 of 5 stars
$26.86
-5.6%
$46.13
+71.7%
+0.7%$1.61B$164.58M-28.88254
SKIN
Beauty Health
2.5123 of 5 stars
$11.89
-3.8%
$19.75
+66.1%
-30.4%$1.58B$365.88M-66.061,034Analyst Report
Positive News
VCYT
Veracyte
1.9067 of 5 stars
$21.83
-6.1%
$30.20
+38.3%
-26.1%$1.58B$296.54M-43.66761
This page (NASDAQ:ADUS) was last updated on 3/29/2023 by MarketBeat.com Staff